Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 35 of 100
International
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By
James Paton
,
Riley Griffin
and
Bloomberg
May 26, 2020
Health
Hydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By
John Lauerman
and
Bloomberg
May 22, 2020
Newsletters
Moderna’s coronavirus vaccine expectations game
By
Tech Reporter
May 21, 2020
Health
Tobacco giants are getting into the coronavirus vaccine race
By
Senior Editor
May 21, 2020
Health
Moderna releases promising—but early—new coronavirus vaccine data
By
Editorial Team
May 18, 2020
Magazine
The CEO who keeps animal pharm growing
By
Financial Writer
May 16, 2020
Health
Antibody testing will be key—once we understand what the results mean
By
Industry Analyst
May 12, 2020
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By
Investment Desk
May 7, 2020
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By
Blockchain Reporter
May 1, 2020
Newsletters
The communities we forget during COVID-19
By
Tech Reporter
April 30, 2020
Health
Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By
Digital Assets Editor
April 30, 2020
Health
The coronavirus pandemic is impacting critical research into neuromuscular diseases
By
Crypto Correspondent
April 28, 2020
Tech
How a pharmacy delivery startup has capitalized on the coronavirus pandemic
By
Trading Desk
April 21, 2020
Magazine
Big Pharma has the chance to come to the world’s rescue
By
Digital Assets Editor
April 20, 2020
Commentary
Prescription drug costs are spiraling, but price controls are the wrong solution
By
Editorial Team
April 18, 2020
Most Popular
Politics
Trump's FAA punishes most of nation's air traffic workers by only giving $10,000 bonuses to the 776 with perfect...
By
Josh Funk
and
The Associated Press
Banking
Suddenly, the Fed interest rate cut in December looks like it is very much back on the table
By
Trading Desk
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Editorial Team